Expression pattern of TLR-4 and MyD88 in EOC cells.

Slides:

Advertisements

Similar presentations

Glioma-derived soluble factor(s) enhance IL-10 signaling.

Advertisements

Enhanced DNA damage in IDH1 mutant glioma cells.

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.

Expression of cell cycle regulatory genes during primordial-primary follicle transition in the mouse ovary Chang-Eun Park, M.S., Kwang-Yul Cha, M.D.,

CHK1 downregulation upon ERG overexpression.

Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.

Collagen-dependent phosphorylation of eIF4E in PDAC cells.

Overexpression of BTAK/Aurora-A in ovarian carcinoma.

NICD1 immunohistochemical staining in normal and tumor tissue.

USP2a overexpression modifies the microRNA expression profile of prostate cells. USP2a overexpression modifies the microRNA expression profile of prostate.

Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.

SIRT1 is downregulated in human gastric cancer (GC).

PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. A,

Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous.

Quantification of NMT knockdown.

Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.

TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.

Increased CCL5 expression, infiltration of Treg cells, and apoptosis of CD8+ T cells in human colorectal tissues. Increased CCL5 expression, infiltration.

B7-H1–induced reverse signals in myeloma cells.

Epigenetic regulation of p16INK4a in human gastric cancer.

BORIS mRNA expression in DNMT deficient HCT116 cell lines.

BME treatment increases granzyme B expression in NK 3.3 cells.

Protein expression profile in a dasatinib-resistant cell line.

LINC00092 binds with PFKFB2 to promote ovarian cancer metastasis.

IL6 mRNA is not detected in metastatic prostate cancer cells.

ALDH1A3 is mainly responsible for the ALDH activity in two human cholangiocarcinoma lines. ALDH1A3 is mainly responsible for the ALDH activity in two human.

Overexpression of JMJD2B in clinical bladder cancers.

Quercetin induces arrest in G1 phase of cell cycle in P39 xenografts.

Ki-67 expression is dynamically controlled by a cell-cycle–regulatory network. Ki-67 expression is dynamically controlled by a cell-cycle–regulatory network.

CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection of CXCR4 siRNAs. CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection.

VEGF expression in neoplastic and normal prostate tissue.

A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.

Effect of TLR-4 ligation with LPS on NF-κB activation in EOC cells: (A) MyD88+ and (B) MyD88− EOC cells were treated with 10 μg/mL LPS for 1, 2, and 4.

Active AR signaling in enzalutamide-resistant xenograft tumors.

A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety of 24 human cell lines. A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety.

In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. A,

IGF-IR in human head and neck cancer.

Activation of mTOR signaling (increased phosphorylated S6 ribosomal protein) and loss of inhibition of IRS-1 in human endometrial carcinomas. Activation.

RT-PCR and Western blot analysis of cIAP2 mRNA and protein expression in ovarian cancer cells. RT-PCR and Western blot analysis of cIAP2 mRNA and protein.

Pharmacodynamic evaluation of VT-464 and ABI in MR49F xenograft model.

Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs.

Analysis of mRNA and protein levels of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 genes in OSFs compared with normal controls. Analysis of mRNA and protein.

DNA demethylation reactivates GSN expression in gastric cancer cells.

Nested RT-PCR of Mammaglobin and CK19 mRNA in plasma and circulating cells of controls (C) and patients (T) with breast cancer. Nested RT-PCR of Mammaglobin.

SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.

Representative photograph of somatic mutations detected by PCR-SSCP.

Reduced klotho expression in pancreatic cancer.

Characterization of DNA-PK and PARP-1 levels and activities in the cell lines studied. Characterization of DNA-PK and PARP-1 levels and activities in the.

Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.

Tivantinib does not inhibit MET function.

MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E. MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E.

Expression of HO-1 by the FAP+/F4/80+ tumoral macrophages.

Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.

Γ-TmT reduces serum E2 levels and induces estrogen-metabolizing enzyme CYP1A1 in E2-treated ACI rats. γ-TmT reduces serum E2 levels and induces estrogen-metabolizing.

Wnt5A decreases ROR1 expression through proteasomal degradation.

Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3 S284 through MDM2. Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3.

Levels and activity of c-myc are increased in a series of stably transfected DAOY and UW228 medulloblastoma cell lines. Levels and activity of c-myc are.

TGFβ1/Smad3 signaling suppresses IFNγ production via an E4BP4-dependent mechanism in NK-92 cells. TGFβ1/Smad3 signaling suppresses IFNγ production via.

P53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma. p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo.

A and B, linearity of the preamplification step shown by a similar expression pattern of ERα mRNA in four breast tumor samples pre– and post–linear amplification.

PARP1 suppresses the transcription of PD-L1 in cancer cells.

Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.

Expression of chemokine receptors in A-498 cell line.

Effects of NMT siRNAs on MARCKS and c-Src.

RGS16 expression is decreased in chondrosarcoma and RGS16 transfection counteracts the effects of miR-181a on VEGF and MMP1 expression. RGS16 expression.

Tobacco-specific carcinogens induce methylation, DNA adducts, DNA damage, and activation of DNMT1. Tobacco-specific carcinogens induce methylation, DNA.

Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.

PD-L1 expression is not associated with PTEN expression status in melanomas. PD-L1 expression is not associated with PTEN expression status in melanomas.

Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.

Silencing E4BP4 abrogates the promoting effect of SMAD3 knockdown on IFNγ production in NK-92 cells. Silencing E4BP4 abrogates the promoting effect of.

Presentation transcript:

Expression pattern of TLR-4 and MyD88 in EOC cells. Expression pattern of TLR-4 and MyD88 in EOC cells. A, evaluation of TLR-4 mRNA expression by reverse transcription-PCR from OSE and EOC cell lines. B and C, Western blot analysis for TLR-4 and MyD88 protein expression from EOC cell lines and ovarian cancer tumor samples. +, positive control; −, negative control (no reverse transcription). D, laser capture microdissection of ovarian cancer cells from tissue sections before (Pre) and after dissection (Post). E, Western blot analysis for the expression of TLR-4 and MyD88 by ovarian cancer cells following laser microdissection. Lane 1, positive control (macrophages); lane 2, 6,000 EOC cells microdissected by laser. Representative of 10 tumors evaluated. Michael G. Kelly et al. Cancer Res 2006;66:3859-3868 ©2006 by American Association for Cancer Research